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Rationale
There were three notable milestones for health research in England during the 1990s. The NHS R&D programme was
established and it prioritised research on themes such as the primary-secondary care interface and initiated regional R&D
programmes. The Culyer Report led to the first comprehensive strategy for funding research within the NHS, while the
Mant strategic review of research in primary care stimulated the setting up of primary care research networks. However,
by the time the three waves of primary care trusts were introduced in 2000-02, 303 in all, opportunities for obtaining
NHS funding for promoting R&D in primary care were much more restricted, especially from regional sources.
Objective
Hillingdon Primary Care Trust (PCT), as a first wave Trust, located in West London foresaw the problems that so many
PCTs would soon be facing and, with support from North Thames Region’s R&D Directorate, commissioned an R&D
strategy.
Introduction
During the months leading up to the research project, significant national policy developments were announced. The
timetable was set out for implementing the research governance framework that will ensure that all R&D carried out in
the NHS meets expected standards (for example, Trusts’ local implementation plans were required to be formulated by
July 2002). National initiatives to promote R&D in primary care were announced: the designation of teaching PCTs in
areas of disadvantage, the identification of 30 or more PCTs to act as “hosts” for research management and government
(RM&G) on behalf of other PCTs and networks, and a scheme to subsidise fees for GP practices obtaining accreditation
by the Royal College of General Practitioners (RCGP). Further clarification of the modernisation of the NHS R&D
funding support was issued. In future there will be two systems, Support for Science (SfS) covering NHS costs of
individual studies including NHS staff time, and Priorities and Needs Funding (PNF) which will address principal health
issues and priorities. The essence of the PNF is “collaboration” between NHS organisations and academic research
groupings with a subject, for example, cancer, being the unifying factor.
There are five research networks of relevance to Hillingdon PCT. WeLReN is the best known. It covers the eight PCTs
in west London and all individuals (NHS, academic) involved in primary care can join. It offers research training and
mentoring, with project grants of about £10,000 being awarded to multidisciplinary teams. Three networks that general
practices may join are organised by the Medical Research Council, Medicines Control Agency and Royal College of
General Practitioners (RCGP); the first two rely on practices contributing routine data on patient contracts.  The West
London Cancer Research Network was set up in 2001 to provide an infrastructure for trials of cancer treatment and it is
now recognised that primary care-based trials, e.g. palliative care, are needed. The London Health Observatory could
assist with public health investigations and there is a national R&D network, C.H.A.I.N., linking research active
professionals. 
Hillingdon PCT is an example of the rapid and extensive remodelling of primary care structures and services currently
underway in the NHS. The PCT now incorporates a wide range of services previously located in the acute and
community sectors, thus making it an ideal setting for multidisciplinary research. It has close working relations with
Hillingdon Local Authority and Hillingdon Hospital, which provides over 90% of secondary care for local residents. A
“snapshot” survey of PCT staff in mid-2000 revealed a kernel of research interest and experience that could be nurtured.
The National Research Register contains very few ongoing Hillingdon primary care projects (two sponsored by
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WeLReN). The PCT, in common with most PCTs in London, does not receive support from the NHS R&D Levy.
Methodology
Over four months between February and May 2002 researchers from Brunel University in West London interviewed 20
representatives of “stakeholder” groups within the PCT and the wider Health Economy. They contacted academic
departments focusing on health research, the West London Research Network (WeLReN) and the pharmaceutical
industry, and held an “emerging findings” workshop..
Findings
Areas of research interest
The stakeholder interviews identified numerous areas of research interest. The clinical areas were in line with the
national service framework priorities of cancer, coronary heart disease and mental health, as well as other chronic
disorders causing high patient demand, for example, diabetes and asthma. Organisational issues, such as nurses as care
managers, multi-disciplinary team working, and commissioning policies, were mentioned. Integrated care pathways,
involving research across the interface between acute and primary sectors, was another important area [and highlighted
in the CHI report (June 2002) on the Hillingdon Hospital NHS Trust].
Partnerships / Collaborations
The importance of forming external alliances with collaborators was stressed in many interviews. Academic partners
were identified as well as Hillingdon Social Services and the voluntary sector, WeLReN research network and
pharmaceutical companies. The latter could, with PCT investment, assist with funding the R&D infrastructure as well
as providing resources for clinical studies.
Developing a research capacity
A need was felt to develop a primary care research capacity and to promote an evaluative culture for all primary care
professionals. As research training was considered to be ad hoc various approaches were suggested: enhancing skills for
audit; approving GP practices as research practices; offering training and career development to research active GPs;
and creating a culture for nurses where research becomes part of everyday activities. Some felt that all the workforce
should be research aware and have skills to understand research findings to inform practice. Opinion was mixed about
providing protected time for clinical researchers. Some thought it would divert commitment from pressurised services,
while others thought it could act as an inducement when recruiting, and retaining staff in a very competitive labour
market.  WeLReN provided most of the training courses. These included methodology workshops and master classes on
research topics and themes. WeLReN was very supportive and the networking opportunities were helpful. Timetabling
of courses along with clinical duties was a concern.
Information services
The PCT is served by library services based in Hillingdon and Mount Vernon Hospitals and the library staff provide
literature searches on request and training for searching databases. Staff in GP practices can access the electronic
information systems remotely from their offices, but community nurses and health visitors based in community clinics
do not have the same access as yet. This is a manifestation of a general problem over the IT system serving the
community services; the community and therapy services databases are not as potentially useful as research resources as
is the EMIS system in GP practices. A new EMIS community system is currently being trialled and it is hoped that it
will overcome the existing problems. Whilst concern was expressed about the limitation of the EMIS databases for
longitudinal research, and generally about the reliability of clinical coding, interviewees acknowledged that audit
facilitators were successfully interrogating the databases, and that disease registers were potentially very useful as a
research resource. (Many Hillingdon GP practices do not yet have a CHD or diabetes disease register). However
significant work would have to be done to improve the accuracy and comprehensiveness of clinical data entry to achieve
the potential of the EMIS system.
Funding for research
Opinion was mixed over policies for funding research in the PCT but it rather depended upon the perspective adopted.
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Immediate financial and resource constraints were recognised as potentially impeding longer-term strategic development
of research and development capability. An indirect approach was suggested by one person - opportunities for personal
development and training should be written into job descriptions. Most thought that any significant research programme
with which the PCT was involved should be part of a wider programme with other PCTs. Some welcomed the idea of
pharmaceutical funding initially to build up the infrastructure, but others were cautious in case market interests drove
the research agenda.
Perspectives on developing an R&D strategy
On balance, the interviewees considered that the PCT should become involved in research, though not necessarily
aspiring to become recognised as a “research” PCT.  But the PCT needed to decide whether to develop its research
capacity in-house or via collaboration with expert partners. Almost all considered some kind of collaboration with
academic partners was desirable. In the longer term the PCT needs to create a nurturing culture whereby research
becomes part of the everyday work of clinicians, administrative and other support staff, and encourages workforce
retention; research governance would become as much a part of primary care as clinical governance, and all the
workforce would become research aware. Researchers themselves need academic support and protected time to deliver
on research outputs.
At present the PCT does not have a formal structure in place to undertake the management functions of research
governance. Options were identified: the PCT could develop its own structure by appointing a manager to co-ordinate
an R&D office.  This could be a joint appointment with an academic institution.  Alternatively, the PCT could contract
out services to the Hillingdon Hospital’s or Mount Vernon Hospital’s R&D Office. Other options are the local “host”
PCT, when it is identified, and Imperial College. A preference was expressed, however, for the service to be sited in
Hillingdon and in a primary care setting if possible as this would facilitate development of an R&D capability within the
local Health Economy.
Hillingdon is fortunate in having three health research academic institutions in close proximity - Brunel University,
Buckinghamshire Chilterns University College and Imperial College. Senior academics in all three expressed their
enthusiasm for forming research partnerships with the PCT. At Brunel, the Department of Health studies and Social
Studies already has a number of links with local trusts, including Hillingdon PCT, particularly in nursing, occupational
therapy and social work. Research training workshops are held, and research collaborations are being formed.
Buckinghamshire Chilterns has a Research Centre for Health Studies, which is involved in research with nearby PCTs.
It also has research and tutoring links with Hillingdon Hospital. Within Imperial College, the Department for Primary
Health Care and General Practice at Charing Cross Hospital is closely associated with WeLReN and fosters a multi-
disciplinary approach to research. It offers training modules in research methodologies.
Conclusions
Optimal research strategies
The report presents three alternative research strategies for Hillingdon PCT based on the policy background and
resources available, as well as the opinions of those interviewed. The PCTBoard would need to weigh up the advantages
of doing, or not doing research taking account of the curtailment of innovative opportunities in the health economy, the
need for developing research awareness within the PCT, recruitment and retention of staff, and the impact that non-
participation could have on Hillingdon Hospital’s R&D strategy.  Regardless of the strategy of choice, the PCT needs to
arrange the management of its research governance, since at least a minimal amount of research activity will continue
to be undertaken for academic dissertations and as a requirement for clinical posts. These options are not mutually
exclusive and some approaches could follow sequentially or in parallel as part of a long-term strategy.
Hillingdon as a research led PCT
Dedicated staff would be required to lead research in collaboration with other groups, as well as dedicated clinicians,
including nurses, and accommodation. Seed funding would be needed from the PCT. Although the Trust has some
research active staff, none has experience of large-scale leadership of research so such a strategy would need to be
medium or long term, developed in partnership with academic collaborators.
35
Hillingdon as a research friendly PCT
This could include any of three elements. Firstly, Hillingdon PCT being a contributor to non-commercial externally led
research. In this strategy, the PCT could participate in research of interest to the PCT, led possibly by an academic
department, by another PCT or an acute Trust, but without the same level of local R&D resources and leadership. It
could also be a contributor to commercial pharmaceutical research. Pharmaceutical research must have a sponsor that
undertakes the research governance responsibilities, while companies accept responsibility for indemnity for non-
negligent harm. Pharmaceutical companies favour primary care settings that are well organised for research preferably
with a dedicated nurse and accommodation and good relationships with secondary care and local ethics committees.
Thirdly, Hillingdon PCT could commission research, relying on academic departments of local universities or other
organisations and agencies. 
Hillingdon PCT as being non-active in research
Such a strategy would deprive the PCT of a local evidence base, make it difficult for staffing groups to become involved
in research, could affect morale and, in turn, affect recruitment and retention.  The PCT would also lose the opportunities
for forming research partnerships and taking up initiatives currently available.
Recommendations
This is a watershed time for primary care research. Partnerships and collaborations are being formed or reinforced
between academic centres and PCTs.  The general level of primary care research and plans for developing research
capacity will be expanded and developed and there will be clear advantages in forming alliances and making
commitments now if a research portfolio is desired in the future.  For the time being, Hillingdon PCT is unlikely to take
on the responsibility of a research lead or host PCT, but we feel it would be ideal if the PCTappointed an R&D manager,
developed a small unit to facilitate research, and explored possibilities of working with local networks and partners.
Three-year timetables are outlined in the full report as this abstract was taken from the Executive Summary.
Presented
This abstract was the Executive Summary presented for discussion by Dr Robin Dowie at the Hillingdon Primary Care
Trust R&D Committee Meeting in North West London on 26th July 2002. Professor Joy Townsend later submitted the
final report for consideration by the Trust on 29th August 2002. 
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